This is a response to a a post in another group - with permission to share -
"I left a mesage with my GP this afternoon to call me regarding the letter of clinical need. He said he wasn't sure he would be able to provide it now as he had had a meeting with someone from the CCG this afternoon. They advised that new guidance was being issued next week to confirm the black listing of T3 as there was insufficient evidence that T3 treatment was more effective than T4 only (that's a new one huh?). They also said from that point going forward it can only be prescribed in secondary care under the continued guidance of an NHS consultant."
I wonder is the new guidance going to be Nationwide??
I shared this on the ITT page and this post links to it.
"I strongly suspect that the news that’s filtering in about T3 being blacklisted is a result of the PAC document we received this week. PAC is part of prescQIPP who initiated the deprescribing of T3 back in 2015 and is the reason it is now ‘blacklisted’ ‘double red tagged’ ‘restricted’ or whatever you want to call it.
Their remit for the past three years has been to get this drug off the the formulary and away from patients for no other reason that the cost of it. If Concordia hadn’t have abused their position in the market I doubt we’d be having this issue.
Our FOI for the audit trial shows clearly the original prescQUIPP document landed on the desk of our CCG and was rubber stamped without discussion. It was simply a ‘oh look, a document from prescQIPP that shows we can a save a ton of money, along with evidence it doesn’t work (!) lets say yes’ and here we all are three years later still fighting this horrible document, and they’ve now seen fit to issue another one.
Hypothyroidism is only one of ten conditions that are eligible for lifelong free prescriptions. Only ten, let that sink in for a moment. That’s why we’re such a problem to them, that and the fact their lack of understanding, education, general stupidity prevents them from from actually being able to diagnose and treat Thyroid patients.
In the PAC doc it states:
“Needs of the community,
Current high cost of treatment with liothyronine associated with a small number of patients represents a financial risk to the whole healthcare economy and will result in cost pressure to other treatment areas.”
So they’re willing to sacrifice us, thyroid patients, for the sake of the healthcare economy?!
Our targets for the campaign should be to challenge PAC and prescQIPP on this document (I’ll post it in the files section, with our rebuttal for information) the trouble here is if I remember correctly prescQIPP refused to answer FOI requests, came up with some excuse why they don’t have to respond to FOI’s. How can that be right?
Our CCG are meeting this afternoon to discuss the PAC document, I suspect other CCGs will be doing the same. I’ll try and find out the outcome and post it as soon as I find out.